Loren Miller, MD, MPH is a Professor of Medicine at the David Geffen School of Medicine at UCLA, Chief of the Division of Adult Infectious Diseases at Harbor-UCLA Medical Center, and Associate Site Director for the UCLA Clinical and Translational Science Institute (CTSI) at the Harbor-UCLA/Lundquist Institute campus. Dr. Miller has completed fellowships in Infectious Diseases and Health Services Research. His research focuses on treatment and prevention of skin infections, Staphylococcus aureus infections, urinary tract infections, and healthcare-associated infections caused by multi-drug resistant organisms (MDROs).
Dr. Miller has served as Chair of the Gram-Positive subcommittee of the Antibiotic Resistance Leadership Group (ARLG) been the Principal Investigator or Co-Investigator on many investigations and clinical trials sponsored by the NIH, CDC, AHRQ, and other government research agencies. He has authored over 175 manuscripts in peer-reviewed literature. His current research interests are treatment and prevention of skin infections and other common infections and studying methods to improve care delivery and outcomes for common infectious diseases.
Notable recent publications:
Miller LG, McKinnell JA, Singh R, Gussin G, Kleinman K, Saavedra R, Mendez J, Catua TD, Felix J, Chang J, Heim L, Franco R, Tjoa T, Stone ND, Steinberg K, Beecham N, Montgomery J, Waters D, Park S, Tam S, Gohil S, Robinson PA, Estevez M, Lewis B, Shimabukuro JA, Tchakalian G, Miner A, Torres C, Evans KD, Bittencourt CE, He J, Lee E, Nedelcu C, Lu J, Agrawal S, Sturdevant G, Peterson E, Huang SS. Decolonization in Nursing Homes to Prevent Infection and Hospitalization. New England Journal of Medicine 2023; 389:1766-77. PMID: 37815935.
Miller LG, Singh R, Eells SJ, Gillen D, McKinnell JA, Park S, Tjoa T, Chang J, Rashin S, Macias-Gil R, Heim L, Gombosev A, Kim D, Cui E, Lequieu J, Cao C, Hong SS, Peterson EM, Evan KD, Launer B, Tam S, Bolaris M, Huang SS. Chlorhexidine and Mupirocin for Clearance of Methicillin Resistant Staphylococcus aureus Colonization After Hospital Discharge: A Secondary Analysis of the Changing Lives by Eradicating Antibiotic Resistance Trial. Clinical Infectious Diseases 2023; 76(3):e1208-e1216. doi: 10.1093/cid/ciac402. PMID: 35640877.
Miller LG, Flores EA, Launer B, Lee P, Kalkat, P, Derrah P, Agrawal S, Schwartz M, Steele G, Kim T, Kuvhenguhwa K. Safety and Tolerability of Tedizolid as Oral Treatment for Bone and Joint Infections. Microbiol Spectr 2023;11(5):e0128223. PMID: 37750695.
Heim LT*, Miller LG*, Singh RD, McKinnell JA, Catuna TD, Estevez M, Evans KD, Tjoa TK, Gussin GM, Dahl SD, Budy L, Peterson EM, Huang SS. Double-swab 5% versus single-swab 10% iodophor for reducing methicillin-resistant Staphylococcus aureus with routine chlorhexidine bathing. Infect Control Hosp Epidemiol 2022; 43:1937-1939. (*= co-first author). PMID: 34433509.
Chan AA, Flores EA, Navarette M, Phan Tran D, Lee DJ, Miller LG. The Effect of Systemic Antibiotics for Suppurative Skin and Soft Tissue Infections on Skin Microbiome. Open Forum in Infectious Diseases 2022;9:ofac141. PMID: 35450081.
“Man of the Year” Award, MRSA Survivor’s Network, 2011
Management-level Patient Safety Leader Award, Los Angeles County Department of Health Services 2012
Fellow, American College of Physicians (ACP)
Fellow, Infectious Diseases Society of America (IDSA)
Richard Weitzman Award for Meritorious Research in the Biomedical Sciences
2024 Top Ten Clinical Research Achievement Award, Clinical Research (CR) Forum